Target intelligence / Profile preview

ANAPC1 pseudogene 6 (ANAPC1P6)

Target: ANAPC1P6
Molecular classification: Other (Pseudogene)

Overview

ANAPC1 pseudogene 6 (ANAPC1P6) is a non-coding pseudogene related to the functional ANAPC1 gene, which encodes a subunit of the anaphase-promoting complex/cyclosome (APC/C) involved in cell cycle regulation[5]. Unlike ANAPC1, ANAPC1P6 does not encode a protein and is not biologically active. There is no evidence indicating a role in signaling, enzymatic activity, disease, or therapeutic intervention. Pseudogenes like ANAPC1P6 serve as genomic relics without direct clinical or research utility unless exceptions are specifically reported in functional genomics literature—which are absent for this gene[5]. Key point: ANAPC1P6 is a pseudogene, not a functional target, enzyme, or receptor; it is not a current or potential therapeutic target[5].

Other names: ANAPC1P6

Beyond the preview

Go deeper on ANAPC1 pseudogene 6 (ANAPC1P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANAPC1 pseudogene 6 (ANAPC1P6).

Explore the full profile